[Interventional therapy of BPH syndrome]

Area of Science:

• Urology
• Minimally Invasive Surgery
• Medical Device Technology

Context:

• Benign prostatic hyperplasia (BPH) affects a large number of aging men, necessitating effective treatment options.
• Current BPH treatments range from conservative management to surgical interventions with varying risk profiles.
• Patient selection is crucial for optimizing outcomes in BPH management.

Purpose:

• To categorize and compare invasive treatment modalities for benign prostatic hyperplasia (BPH).
• To elucidate the differences in invasiveness, complication rates, and functional outcomes among BPH treatment groups.
• To provide guidance for selecting appropriate BPH procedures based on patient characteristics and desired outcomes.

Summary:

• Invasive BPH treatments are classified into interstitial therapy (e.g., stents), delayed tissue ablation (e.g., laser, microwave, ultrasound), and immediate tissue ablation (e.g., vaporization, resection).
• Delayed ablation techniques often result in less bleeding, preserve sphincter function, and reduce retrograde ejaculation compared to immediate ablation.
• Immediate ablation offers the advantage of avoiding prolonged catheterization but carries higher complication risks.

Impact:

• This classification aids clinicians in making informed decisions for personalized BPH treatment strategies.
• Understanding the nuances of each BPH treatment modality can lead to improved patient satisfaction and reduced morbidity.
• Facilitates a more rational approach to managing benign prostatic hyperplasia, optimizing therapeutic efficacy and safety.